Develop a comprehensive understanding of target discovery strategies in cancer immunotherapy, the emerging role of tissue-derived extracellular vesicles (Ti-EVs) for disease target identification, and the utilization of biomarkers for lysosomal storage diseases.
This event was hosted by ASGCT on April 23, 2024. Enjoy this sample of ASGCT and Molecular Therapy's member-exclusive content, and consider joining to access live, virtual events like these for FREE and for access to discounts on publishing in the Molecular Therapy Family Journals and discounts to attend all ASGCT events, including the Annual Meeting!
asgct.org/join
Moderator: Roland W. Herzog, PhD, IU School of Medicine
Speakers:
Fabiana Perna, MD, PhD, Moffitt Cancer Center
Target discovery strategies for the development of future cancer immunotherapies
Tristan Scott, PhD, City of Hope
New role of Tissue-derived (Ti-EVs) in identification of disease targets
Nicola Brunetti-Pierri, MD, Telethon Institute of Genetics & Medicine
Biomarkers for lysosomal storage diseases
22 май 2024
